Related Experiment Videos
Pneumonia
S K Kabra1, T Singhal, R Lodha
1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi. skkabra@hotmail.com
Insights
Pneumonia is a major cause of death in young children, often bacterial. Treatment choice depends on severity and risk factors, with amoxicillin a common option for uncomplicated community-acquired pneumonia.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Pneumonia is a leading cause of mortality and morbidity in children under five.
- Bacterial agents commonly cause pneumonia, diagnosed via clinical features.
- Disease severity is classified by symptoms like tachypnea, chest indrawing, and feeding difficulty.
Purpose of the Study:
- To outline antibiotic selection criteria for pediatric pneumonia.
- To differentiate treatment strategies based on risk factors and disease severity.
Main Methods:
- Classification of pneumonia into community-acquired (with/without risk factors) and severe/non-severe categories.
- Identification of clinical features for diagnosing pneumonia and its severity.
- Review of factors influencing antibiotic choice, including pathogens, resistance, and patient status.
Main Results:
- Amoxicillin is recommended for uncomplicated community-acquired pneumonia in children aged 2-60 months.
- Alternative oral antibiotics include cephalosporins and cotrimoxazole.
- Non-severe pneumonia with risk factors may be treated with cefuroxime or amoxicillin clavulinic acid for 7-14 days.
Conclusions:
- Antibiotic selection for pediatric pneumonia requires careful consideration of etiological agents, disease severity, and patient-specific factors.
- Tailored antibiotic regimens are crucial for effective management of pediatric pneumonia.
Abstract:
Pneumonia is the leading cause of mortality and a common cause of morbidity in children below five years of age. Commonly, pneumonia is caused by bacterial agents. The diagnosis of pneumonia is usually made on clinical features. A child with tachypnea with no chest in-drawing or difficulty in feeding is labeled as pneumonia. Presence of chest in-drawing, difficulty in speech, feeding or cyanosis classifies a child as suffering from severe or very severe pneumonia. Factors that may help in selection of appropriate antibiotics include: knowledge of etiological agents, sensitivity of pathogens to antibiotics, severity of the disease, immune status, nutritional status, previous antimicrobial usages, history of hospitalization, duration of illness, associated complications and cost and safety of antibiotics. For selection of antibiotics pneumonia can be classified in two major categories (a) community acquired, without risk factors, and (b) pneumonia with risk factors. Both these can be further classified as non severe and severe illness. A community acquired pneumonia in a child between 2 months -60 months without risk factors for resistant or atypical organism may be treated with amoxicillin. The alternative to amoxicillin includes oral cephalosporins and cotrimoxazole. In pneumonia with presence of risk factors the antibiotics are decided on basis of individual patients characteristics. A child with non-severe pneumonia should be treated with oral cefuroxime or amoxicillin clavulinic acid for a period of 7-14 days.